eMedicine Specialties > Physical Medicine and Rehabilitation > Upper Limb Musculoskeletal Conditions
Dupuytren Contracture: Follow-up
Updated: Feb 4, 2010
Follow-up
Further Outpatient Care
- Patients with mild Dupuytren disease can be monitored on an infrequent basis via a brief follow-up visit every 6-12 months. In addition to accurate measurement of the progression of the contractures, the follow-up also provides an opportunity to elicit a history of any functional deficits. Further, these visits allow assessment and discussion of the need for surgical referral.
Inpatient & Outpatient Medications
- No medications are known to decrease the symptoms or progression of this condition.
Complications
- The predominant complication is progressive flexion contracture of the digits, with associated functional disability.
Prognosis
- It is difficult to predict which patients may progress to the point of requiring surgical intervention. For patients who do require surgery, the postsurgical prognosis for recovery is good.
Patient Education
- As with any medical condition, the patient should be informed thoroughly regarding the nature of the diagnosis; reassurance should be provided when appropriate.
Miscellaneous
Medicolegal Pitfalls
- There are few legal pitfalls for this disorder other than a failure to inform the patient that surgery is the definitive treatment option.
Special Concerns
- Pregnancy
- There is no known association between Dupuytren contracture and pregnancy.
- This condition is relatively uncommon in women of childbearing age. In the event that such a patient requires treatment for Dupuytren contracture, defer this elective procedure until after the pregnancy.
- Pediatric population - This condition generally is not seen in children.
- Geriatric population - This condition is seen most commonly in elderly persons.
Debra Ibrahim, 4th year medical student, New York College of Osteopathic Medicine, Class of 2008, assisted with the revision of this manuscript.
Evish Kamrava, 4th year medical student, St. George's University School of Medicine, Class of 2009, assisted with the 2008 revision of this manuscript.
Jason Lee, 4th year medical student, St. George's University School of Medicine, Class of 2010, assisted with the 2009 revision of this manuscript.
More on Dupuytren Contracture |
| Overview: Dupuytren Contracture |
| Differential Diagnoses & Workup: Dupuytren Contracture |
| Treatment & Medication: Dupuytren Contracture |
Follow-up: Dupuytren Contracture |
| Multimedia: Dupuytren Contracture |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Bansal V, Naidu SH. Dupuytren's disease. Curr Opin Orthop. 2005;16(4):236-9.
Vi L, Feng L, Zhu RD, Wu Y, et al. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Exp Cell Res. Dec 10 2009;315(20):3574-86. [Medline].
Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord. 2007;8:60. [Medline]. [Full Text].
Bayat A, Cunliffe EJ, McGrouther DA. Assessment of clinical severity in Dupuytren's disease. Br J Hosp Med (Lond). Nov 2007;68(11):604-9. [Medline].
Hnanicek J, Cimburova M, Putova I, et al. Lack of association of iron metabolism and Dupuytren's disease. J Eur Acad Dermatol Venereol. Apr 2008;22(4):476-80. [Medline].
Balaguer T, David S, Ihrai T, et al. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur Vol. Aug 2009;34(4):493-6. [Medline].
Anwar MU, Al Ghazal SK, Boome RS. Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients. J Hand Surg [Am]. Nov 2007;32(9):1423-8. [Medline].
Mavrogenis AF, Spyridonos SG, Ignatiadis IA, et al. Partial fasciectomy for Dupuytren's contractures. J Surg Orthop Adv. Summer 2009;18(2):106-10. [Medline].
Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. Mar 2009;91(3):374-8. [Medline].
Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg [Am]. Nov 2000;25(6):1157-62. [Medline].
Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am]. Jul-Aug 2007;32(6):767-74. [Medline].
Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren''s disease. J Hand Surg [Am]. Sep 2002;27(5):788-98. [Medline].
Starkweather KD, Lattuga S, Hurst LC, et al. Collagenase in the treatment of Dupuytren''s disease: an in vitro study. J Hand Surg [Am]. May 1996;21(3):490-5. [Medline].
Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. Sep 3 2009;361(10):968-79. [Medline].
Trojian TH, Chu SM. Dupuytren's disease: diagnosis and treatment. Am Fam Physician. Jul 1 2007;76(1):86-9. [Medline].
Corrado A, Cantatore FP. [Dupuytren's disease. State of the art and therapeutic perspectives]. Reumatismo. Apr-Jun 2007;59(2):118-28. [Medline].
Breen TF. Wrist and hand. In: Steinberg GG, Akins CM, Baran DT, eds. Orthopaedics in Primary Care. 3rd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999:99-138.
Brinker MR, Miller MD. The adult hand. In: Fundamentals of Orthopaedics. Philadelphia, Pa: WB Saunders; 1999:196-220.
Dupuytren's disease. In: Snider RK, ed. Essentials of Musculoskeletal Care. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1997:198-9.
McGee DJ. Forearm, wrist and hand. In: Orthopedic Physical Assessment. 2nd ed. Philadelphia, Pa: WB Saunders; 1992:168-215.
Rayan GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. Jan 2007;89(1):189-98. [Medline].
Strakowski JA, Wiand JW, Johnson EW. Upper limb musculoskeletal pain syndromes. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: WB Saunders; 1996:756-82.
Further Reading
Related eMedicine topics:
Dupuytren Contracture [Dermatology]
Dupuytren Contracture [Orthopedic Surgery]
Dupuytren Contracture [Rheumatology]
Hand, Dupuytren Disease
Clinical trials:
Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture
Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing
Health-Related Quality of Life in Patients With Dupuytren's Disease
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Splinting for Dupuytren's Contracture Release
Keywords
Dupuytren contracture, Dupuytren's contracture, Dupuytren's disease, Dupuytren disease, PIP joint, MCP joint, palmar fasciitis, palmar fibromatosis, Viking disease, metacarpophalangeal joint deformity, MCP joints, fasciectomy, proximal interphalangeal joint deformity, PIP joints
Follow-up: Dupuytren Contracture